Physician profile
Michael Eric Mathieu
NPI 1215908223
$657.86
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.94 · 2022: $387 · 2023: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $218.67 | 2021-2023 | |
| Leo Pharma INC. | $164.63 | 2021-2023 | Adbry |
| Janssen Biotech, INC. | $63.22 | 2021-2023 | Simponi Aria, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $60.26 | 2022-2023 | |
| Dermavant Sciences, INC. | $30.41 | 2022-2023 | Vtama |
| Lilly USA, LLC | $19.87 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.36 | 2022 | |
| Pfizer INC. | $18.63 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.60 | 2022 | |
| Almirall LLC | $17.28 | 2023 | Klisyri |
| Amgen INC. | $15.21 | 2022 | |
| Genzyme Corporation | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mathieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.